The government just announced the price Medicare pays for the diabetes-slash-weight loss drug Ozempic will soon be negotiated lower as part of a new program designed to bring down prices. One of 15 drugs now subject to price changes to […]
The following is from Gallup News. A new Gallup and West Health survey finds that 46% of Americans say the country is headed in the wrong direction regarding healthcare policy under President-elect Donald Trump. About 31% say it’s on the
(GALLUP) Nearly half say US healthcare is headed in the wrong direction Read More »
The following is from a Senate Budget Committee release by Sen. Grassley. The nonpartisan Congressional Budget Office (CBO) has issued its fiscal analysis of the Biden-Harris administration’s Medicare Part D Premium Stabilization Demonstration Program. The CBO estimates that the program—which the Centers for
(READ) Biden-Harris Medicare Plan to Cost Taxpayers $21B Read More »
The following information is from Public Citizen. WASHINGTON, D.C. — According to a new analysis featured today in JAMA Internal Medicine, privatized Medicare Advantage plans have raised Medicare’s costs by $612 billion since 2007, including $82 billion last year alone. The authors — physicians
The following is from Reuters. Drugmakers including Pfizer (PFE.N), Sanofi (SASY.PA) and Takeda Pharmaceutical (4502.T) plan to raise prices in the United States on more than 500 drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors. Excluding different doses
Drugmakers set to raise prices on 500+ drugs this month Read More »
News reports indicate that Dan Ziegler, a Washington lobbyist counting among his clients PhRMA, Pfizer, Merck, Sanofi, Eli Lilly and Amgen, will join House Speaker Mike Johnson’s office as policy director. Public Citizen, a nonprofit consumer advocacy organization that works
(READ) New House Speaker Mike Johnson hires Pharma lobbyist to join his staff Read More »
The following is an excerpt from MedPage Today. Agents and brokers who sell Medicare plan coverage often steer their clients to a Medicare Advantage (MA) plan because it earns them a higher commission compared with a Medigap supplemental plan with
The following is an excerpt from Becker’s Hospital Review. A federal jury convicted a Virginia pharmacist Feb. 9 for his role in a prescription drug scheme that aimed to defraud Medicare of $1 million. Alongside co-conspirators, Ronald Beasley II, PharmD, the 33-year-old
Pharmacist convicted in $1 million Medicare fraud scheme Read More »
